EichorEICHOR
Location: Gyeonggi Do Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Gyeonggi Do

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants Wit
Phase 1 · BeOne Medicines · NCT06427941A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Eli Lilly and Company · NCT06338995A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Janssen Research & Development, LLC · NCT06319820Pan Tumor Rollover Study
Phase 2 · Bristol-Myers Squibb · NCT03899155A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Livi
Phase 2 · Novo Nordisk A/S · NCT06717698A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chro
Phase 4 · Sanofi · NCT07053423A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, a
Phase 3 · Bayer · NCT05196035A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compar
Phase 3 · BeOne Medicines · NCT06943872A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in
Phase 3 · Sanofi · NCT06241118BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Phase 1 · BeOne Medicines · NCT06120283A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · Bayer · NCT06452277A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · Hoffmann-La Roche · NCT05878769Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-posi
Phase 3 · Jazz Pharmaceuticals · NCT06282575A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leuke
Phase 3 · Janssen Research & Development, LLC · NCT06852222CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in Peop
Phase 3 · Novo Nordisk A/S · NCT07207811A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment
Phase 1 · Servier Bio-Innovation LLC · NCT07006688An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With A
Phase 1 · BeOne Medicines · NCT06589596A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Al
Phase 3 · Merck Sharp & Dohme LLC · NCT06952504A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Len
Phase 3 · Regeneron Pharmaceuticals · NCT06149286A Beta-only IL-2 ImmunoTherapY Study
Phase 1/Phase 2 · Medicenna Therapeutics, Inc. · NCT05086692Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Phase 2 · Tectonic Operating Company, Inc. · NCT07473700A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lympho
Phase 3 · BeOne Medicines · NCT06846671A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor
Phase 3 · Bayer · NCT05457283A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Di
Phase 3 · Regeneron Pharmaceuticals · NCT06091254A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Phase 3 · Takeda · NCT07623161A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Phase 3 · Hoffmann-La Roche · NCT07170150Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Phase 3 · Bristol-Myers Squibb · NCT07116967A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib
Phase 3 · BeOne Medicines · NCT06742996AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type
Phase 3 · Novo Nordisk A/S · NCT07533175A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Phase 3 · Novo Nordisk A/S · NCT07567001
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.